Author

L. Fazlollahi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Califano· 1 shared A. L. Kung· 1 shared A. R. Rainey· 1 shared D. Diolaiti· 1 shared D. J. Yamashiro· 1 shared E. S. Gaviria· 1 shared F. S. Dela Cruz· 1 shared H. Hosoi· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Califano

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification and validation of a non-genetically encoded vulnerability to XPO1 inhibition in malignant rhabdoid tumors - expanding patient-driven discovery beyond the Nof1.

L. J. Marks, D. Diolaiti, P. Mundi, E. S. Gaviria, A. R. Rainey, D. J. Yamashiro, L. Fazlollahi, H. Hosoi, Y. Katsumi, Y. Kuwahara, F. S. Dela Cruz, A. Califano, A. L. Kung

This study identifies XPO1 activation as a non-genetic vulnerability in malignant rhabdoid tumors using patient-driven discovery and validates selinexor as a potential therapeutic.

bioRxiv · Oct 2, 2021 · PreprintCancer Biology